17:27 EDT Capricor Therapeutics (CAPR) files $300M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics responds to FDA posting of dermiocel CRL
- CAPR Lawsuit Alert! Class Action Lawsuit Against Capricor Therapeutics
- Capricor Therapeutics Faces Challenges Despite Strong Cash Position
- Capricor Therapeutics: Promising Developments in Exosome-Based Vaccine and Strategic Engagements with FDA
- Capricor announces first subjects dosed in Phase 1 trial of StealthX